- Home
- NPCE vs EOD Comparison
NPCE vs EOD Comparison
Compare NPCE & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- EOD
- Stock Information
- Founded
- NPCE 1997
- EOD 2007
- Country
- NPCE United States
- EOD United States
- Employees
- NPCE N/A
- EOD N/A
- Industry
- NPCE Medical Specialities
- EOD Investment Managers
- Sector
- NPCE Health Care
- EOD Finance
- Exchange
- NPCE Nasdaq
- EOD Nasdaq
- Market Cap
- NPCE 292.9M
- EOD 245.0M
- IPO Year
- NPCE 2021
- EOD N/A
- Fundamental
- Price
- NPCE $10.27
- EOD $5.63
- Analyst Decision
- NPCE Strong Buy
- EOD
- Analyst Count
- NPCE 6
- EOD 0
- Target Price
- NPCE $16.67
- EOD N/A
- AVG Volume (30 Days)
- NPCE 178.3K
- EOD 118.1K
- Earning Date
- NPCE 11-11-2025
- EOD 01-01-0001
- Dividend Yield
- NPCE N/A
- EOD 9.28%
- EPS Growth
- NPCE N/A
- EOD N/A
- EPS
- NPCE N/A
- EOD N/A
- Revenue
- NPCE $88,570,000.00
- EOD N/A
- Revenue This Year
- NPCE $22.13
- EOD N/A
- Revenue Next Year
- NPCE $6.07
- EOD N/A
- P/E Ratio
- NPCE N/A
- EOD N/A
- Revenue Growth
- NPCE 23.32
- EOD N/A
- 52 Week Low
- NPCE $5.45
- EOD $3.73
- 52 Week High
- NPCE $18.98
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- NPCE 65.20
- EOD 44.83
- Support Level
- NPCE $9.65
- EOD $5.61
- Resistance Level
- NPCE $10.12
- EOD $5.71
- Average True Range (ATR)
- NPCE 0.40
- EOD 0.05
- MACD
- NPCE 0.08
- EOD -0.02
- Stochastic Oscillator
- NPCE 99.88
- EOD 7.89
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.